- Johnson & Johnson Study Suggested Hip Device Could Fail in Thousands More
- January 31, 2013
- Law Firm: Lieff Cabraser Heimann Bernstein LLP - San Francisco Office
The New York Times reports that an internal analysis conducted by Johnson & Johnson in 2011 after it recalled a troubled hip implant projected that the all-metal device could fail within five years in nearly 40 percent of patients who received it, newly disclosed court records show.
The analysis, which the company has never released, suggests that thousands of additional patients may have to undergo painful procedures over the next few years to replace the implant, known as the Articular Surface Replacement, or A.S.R. It also indicates that the episode's cost to Johnson & Johnson will continue to grow.
The analysis was part of a small set of records unsealed Friday by a judge in California Superior Court in Los Angeles as part of pretrial proceedings in a lawsuit brought by a patient against the DePuy Orthopaedics unit of Johnson & Johnson. Over 10,000 lawsuits have been filed against DePuy by patients who got an A.S.R. If the California case goes forward this week as scheduled, it will be first of those cases to go to trial.